x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

12:10

Rethinking Haloperidol in Geriatric Delirium

Psychopharmacology and Psychiatry Updates ·

2024/09/28

In this episode, we explore a recent study challenging the safety concerns surrounding haloperidol use in older patients post-surgery. We discuss its implications for managing delirium and compare it to other antipsychotics. Could haloperidol be the unsung hero in our psychopharmacological arsenal? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 59 Comparative Safety of Oral Antipsychotics for Adverse Events in Adults After

en

07:34

Antipsychotics in Pregnancy: A Balancing Act

Psychopharmacology and Psychiatry Updates ·

2024/09/23

In this episode, we explore the use of atypical antipsychotics during pregnancy for women with bipolar disorder. We discuss recent research findings, potential risks, and the delicate balance between managing maternal mental health and fetal safety. How do clinicians approach this challenging clinical decision? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Risks of Using Antipsychotics During

en

11:26

Risperidone in Youth Anorexia: A Promising Solution?

Psychopharmacology and Psychiatry Updates ·

2024/09/18

In this episode, we explore the use of risperidone in treating anorexia nervosa in children and adolescents. We discuss a groundbreaking study examining its efficacy and tolerability. Can atypical antipsychotics like risperidone offer hope for young anorexia patients, or are we still searching for effective pharmacological treatments? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: CAP Smart Takes Vol. 18 Efficacy of Risperidone as

en

09:28

Navigating Lithium: A Guide for Expectant Mothers...

Psychopharmacology and Psychiatry Updates ·

2024/09/13

In this episode, we explore the complexities of managing lithium during pregnancy for women with bipolar disorder. How do lithium levels change throughout pregnancy, and what monitoring is necessary? We discuss dosing strategies, fetal monitoring, and postpartum considerations to ensure the best outcomes for both mother and baby. Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Bipolar Disorder During

en

11:21

DORA: A New Frontier in Insomnia Treatment

Psychopharmacology and Psychiatry Updates ·

2024/09/08

In this episode, we explore the revolutionary potential of daridorexant, a new dual orexin receptor antagonist (DORA) for treating chronic insomnia. We discuss its unique mechanism of action, efficacy, and implications for future insomnia treatment. Could this medication be the key to "turning off" wakefulness in stubborn cases of insomnia? Faculty: Carlos H. Schenck, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 58 Use of Daridorexant for the

en

10:47

Debunking Myths: Lithium Use in Pregnancy

Psychopharmacology and Psychiatry Updates ·

2024/09/03

In this episode, we explore the risks and benefits of using lithium during pregnancy for women with bipolar disorder. We discuss recent research on cardiac malformations and dose-dependent risks. Is the fear of lithium use in pregnancy justified by the latest evidence? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Risks of Using Lithium in Pregnancy

en

11:47

SSRIs and Kids: Escitalopram for Pediatric Anxiety

Psychopharmacology and Psychiatry Updates ·

2024/08/29

In this episode, we explore a groundbreaking study on escitalopram's efficacy in treating generalized anxiety disorder in children and adolescents. We discuss its potential as the first FDA-approved medication for youth anxiety. How might this change our approach to pediatric anxiety treatment? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 18 The Role of Escitalopram in Treating Generalized Anxiety Disorder in

en

13:34

Unraveling Treatment Resistance: A Psychodynamic...

Psychopharmacology and Psychiatry Updates ·

2024/08/24

In this episode, we explore psychodynamic psychopharmacology and its role in addressing treatment-resistant cases. We discuss how patient-doctor relationships, transference, and countertransference can impact medication effectiveness. How might your own unconscious biases influence your prescribing decisions? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships

en

10:53

Psychedelics: A New Frontier in Psychiatry

Psychopharmacology and Psychiatry Updates ·

2024/08/19

In this episode, we explore the therapeutic potential of psychedelic compounds in psychiatry. We discuss their definition, mechanism of action, and potential uses in treating anxiety and depression. How might psychedelics reshape the future of psychopharmacology? Faculty: Sidney LeFay, D.O. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 58 Psychedelics as Transformative Therapeutics

en

12:09

Beyond the Prescription Pad: Navigating Patient...

Psychopharmacology and Psychiatry Updates ·

2024/08/14

In this episode, we explore the concept of patient ambivalence in psychopharmacology. How can understanding a patient's conflicting feelings about treatment improve outcomes? We discuss strategies for recognizing and addressing ambivalence, and its impact on medication adherence and effectiveness. Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships Attending

en

10:53

Unplugging from Vaping: Cessation Strategies for Teens

Psychopharmacology and Psychiatry Updates ·

2024/08/09

In this episode, we explore vaping cessation methods used by US adolescent e-cigarette users. We discuss a study analyzing the prevalence and effectiveness of various quitting strategies, considering factors like demographics and perception of harm. How can healthcare providers tailor their approach to help teens quit vaping? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 17 Adoption of Vaping Cessation Methods by

en

11:12

When Drugs Don't Work: A Psychodynamic Approach

Psychopharmacology and Psychiatry Updates ·

2024/08/04

In this episode, we explore Psychodynamic Psychopharmacology, an innovative approach to treating medication-resistant patients. We discuss how psychological factors influence drug responses and learn techniques to enhance treatment outcomes. Could understanding the meaning patients attach to their medications be the key to unlocking treatment resistance? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From

en

09:43

Rethinking Rx: Benzodiazepines and Suicide Risk

Psychopharmacology and Psychiatry Updates ·

2024/07/30

In this episode, we explore the complex relationship between benzodiazepine use and suicide risk, examining a groundbreaking French study that challenges our understanding of this connection. Is our go-to anxiety treatment potentially increasing suicide risk? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 57 Risk for Suicide Attempts and Suicide Associated With Benzodiazepines

en

14:36

The Psychology of Prescribing: Optimizing Outcomes...

Psychopharmacology and Psychiatry Updates ·

2024/07/25

In this episode, we explore how a psychodynamic approach can shed light on treatment-resistant cases. Can understanding a patient's psychological dynamics be the key to unlocking better outcomes? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships Understanding the Problem of Treatment Resistance

en

11:59

ADHD and Pain: A Surprising Link

Psychopharmacology and Psychiatry Updates ·

2024/07/20

In this episode, we explore the fascinating connection between ADHD, pain sensitivity, and methylphenidate treatment in children. Could methylphenidate help reduce pain sensitivity in pediatric ADHD patients? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 17 Effect of Methylphenidate on Pain Perception Thresholds in Children With ADHD

en

15:08

Restoring Rest: Insomnia Interventions for Depressed...

Psychopharmacology and Psychiatry Updates ·

2024/07/15

In this episode, we dive into the complex world of treating insomnia in patients with major depressive disorder. What's the best approach to help these patients find restful sleep and improve their mood? Join us as we explore a range of strategies, from medication to behavioral interventions. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Treatment Strategies for

en

10:51

Restoring Sleep in Major Depression: Orexin,...

Psychopharmacology and Psychiatry Updates ·

2024/07/10

In this episode, we explore the latest pharmacologic interventions for managing insomnia in patients with major depressive disorder. Can dual orexin receptor antagonists, melatonin agonists, and low-dose doxepin provide relief for those struggling with sleep? Join us as we discuss the advances in treating insomnia and depression. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Navigating Insomnia in Major Depressive Disorder: Advances in

en

11:38

Enhancing Pediatric Depression Treatment: The Role of...

Psychopharmacology and Psychiatry Updates ·

2024/07/05

In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 Is Fish Oil Effective in Youth Depression?

en

12:06

Pharmacological Strategies for Insomnia in MDD

Psychopharmacology and Psychiatry Updates ·

2024/06/30

In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management

en

11:10

Balancing Benefits and Risks: Antipsychotics in...

Psychopharmacology and Psychiatry Updates ·

2024/06/25

In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring. Faculty: Sydney LeFay, D.O. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 56 Antipsychotic Safety in Liver Disease

en

411 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown